SNAPIN Facilitates Progression of Hepatocellular Carcinoma by Hindering Ferroptosis Through KEAP1 Degradation Promotion
Cancer Science · 2026
DOI: 10.1111/cas.70244 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cancer Science, 2026. Verfasst von Xuan Liu und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastroenterology, the First People's Hospital of Yancheng, The Yancheng Clinical College of Xuzhou Medical University, Yancheng, Jiangs…. Hauptthemen laut MEDLINE: Carcinoma, Hepatocellular, Liver Neoplasms, Ferroptosis, Vesicular Transport Proteins. Die Arbeit nennt 42 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Hepatocellular carcinoma (HCC) ranks among the most pervasive forms of cancer worldwide. In our study, we observed a notable overexpression of SNAPIN in human HCC tissues, which was linked closely to patient prognosis. Our experiments demonstrated that SNAPIN enhances the proliferative capacity of HCC cells. The knockdown of SNAPIN induces ferroptosis in HCC cells, whereas its overexpression partially resists the effects of ferroptosis inducers. As suggested by the above experimental findings, SNAPIN facilitates HCC progression by hindering HCC cell ferroptosis. Mechanistically, SNAPIN directly binds to KEAP1, facilitating its degradation via the autophago‐lysosomal pathway, thereby undermining its stability. Consequently, NRF2 and its downstream target gene, GPX4, are upregulated. These alterations effectively mitigate lipid peroxidation damage, and ultimately impede HCC cell ferroptosis, potentially aiding in the progression of HCC. In conclusion, SNAPIN can negatively regulate the stability of KEAP1 protein, thereby initiating the NRF2/GPX4 pathway to hinder ferroptosis in HCC cells, ultimately facilitating HCC progression. Our results substantiate the pivotal function of SNAPIN in promoting HCC development, and this discovery is expected to provide an innovative therapeutic target for clinically managing HCC.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Gastroenterology, the First People's Hospital of Yancheng, The Yancheng Clinical College of Xuzhou Medical University, Yancheng, Jiangsu, China.
- Faculty of Medicine, Yangzhou University, Yangzhou, Jiangsu, China.
ORCID-Profile: Xuan Liu
Zitieren
APA
Liu, X., Xu, W., Li, Z., Li, R., Chen, J., & Wang, J. (2026). SNAPIN Facilitates Progression of Hepatocellular Carcinoma by Hindering Ferroptosis Through KEAP1 Degradation Promotion. Cancer Science. https://doi.org/10.1111/cas.70244
Vancouver
Liu X, Xu W, Li Z, Li R, Chen J, Wang J. SNAPIN Facilitates Progression of Hepatocellular Carcinoma by Hindering Ferroptosis Through KEAP1 Degradation Promotion. Cancer Science. 2026. doi:10.1111/cas.70244
BibTeX
@article{Liu2026,
author = {Liu, Xuan and Xu, Weiling and Li, Zhen and Li, Rongqing and Chen, Jin and Wang, Jianhua},
title = {SNAPIN Facilitates Progression of Hepatocellular Carcinoma by Hindering Ferroptosis Through KEAP1 Degradation Promotion},
journal = {Cancer Science},
year = {2026},
doi = {10.1111/cas.70244}
}
EUVIMED